Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries is currently trading at Rs. 622.00, up by 1.00 points or 0.16 % from its previous closing of Rs. 621.00 on the BSE.

The scrip opened at Rs. 623.95 and has touched a high and low of Rs. 625.60 and Rs. 617.75 respectively. So far 29340 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 653.10 on 03-Mar-2014 and a 52 week low of Rs. 398.50 on 07-Mar-2013.

Last one week high and low of the scrip stood at Rs. 653.10 and Rs. 616.90 respectively. The current market cap of the company is Rs. 128619.28 crore.

The promoters holding in the company stood at 63.65 % while Institutions and Non-Institutions held 28.23 % and 8.11 % respectively.

Sun Pharmaceutical Industries is reportedly planning to enter into Japanese markets, an especially lucrative market for manufacturers of low-cost drugs, through partnerships or acquisitions. The company has expanded in the last few years, mainly through acquisitions, and it is looking out for more purchases.

Mumbai-based pharmaceutical company gets more than half its sales from the United States, the world’s biggest pharmaceuticals market.

Sun Pharmaceutical Industries is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, US and several other markets across the world.